catechin and Atherosclerotic Parkinsonism

catechin has been researched along with Atherosclerotic Parkinsonism in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cho, MH; Choi, JY; Chung, WG; Jin, BK; Kim, DJ; Park, CS; Pie, JE	1

Other Studies

1 other study(ies) available for catechin and Atherosclerotic Parkinsonism

Article	Year
Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate. Neurotoxicology, 2002, Volume: 23, Issue:3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Blotting, Western; Catechin; Dopamine Agents; Homovanillic Acid; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Parkinson Disease, Secondary; RNA, Messenger; Substantia Nigra; Tea; Tyrosine 3-Monooxygenase	2002

Article

Year

Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate.

Neurotoxicology, 2002, Volume: 23, Issue:3

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Blotting, Western; Catechin; Dopamine Agents; Homovanillic Acid; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Parkinson Disease, Secondary; RNA, Messenger; Substantia Nigra; Tea; Tyrosine 3-Monooxygenase

2002